• Cy5 maleimide (non-sulfonated): Practical Guide

  2026-09-07

  Cy5 maleimide (non-sulfonated) provides a thiol-reactive route for fluorescent labeling of cysteine-containing peptides and proteins, with Cy5 optical properties suited to fluorescence detection. It is appropriate when accessible thiols and organic cosolvent handling are acceptable, but it is not an ideal choice for workflows requiring a fully aqueous dye stock or nonspecific amine labeling.

• Honokiol: From Mechanism to Translational Strategy

  2026-09-05

  Honokiol is best positioned as a mechanistically rich research tool for connecting NF-κB signaling, oxidative stress, and tumor-associated vascular biology with more rigorous drug-response phenotyping. This article outlines how translational researchers can deploy the compound without confusing growth inhibition with cell killing or mistaking pathway activity for clinical efficacy.

• EdU Imaging Kits (Cy3) for HCC Proliferation

  2026-09-04

  EdU Imaging Kits (Cy3) translate S-phase DNA synthesis into bright, quantifiable Cy3 fluorescence for microscopy or flow cytometry. The denaturation-free workflow is especially useful for connecting DRG1-driven hepatocellular carcinoma biology with proliferation and lenvatinib-response experiments.

• (R)-MG132 for Proteasome Assay Controls

  2026-09-04

  Use (R)-MG132, the functionally inactive MG-132 enantiomer, to separate proteasome-dependent biology from solvent, peptide-aldehyde, and cellular stress effects. This practical guide applies the control to ubiquitin-proteasome system research and to mechanistic studies of the HNRNPU–PHGDH metabolic axis in cervical cancer.

• Orientia tsutsugamushi and Necroptosis: New Evidence

  2026-09-03

  The 2025 Pathogens study shows that Orientia tsutsugamushi lowers cellular RIPK3 abundance but does not block necroptosis once the RIPK3–MLKL pathway is experimentally activated. Its infection, effector-expression, phosphorylation, and imaging experiments distinguish pathway avoidance from genuine necroptosis inhibition, providing a useful framework for studying scrub typhus pathogenesis.

• 2X Taq PCR Master Mix for Genotyping & Cloning

  2026-09-03

  Turn routine endpoint PCR into a streamlined workflow for genotyping, TA cloning, and molecular validation. Integrated loading dye and Taq-generated adenine overhangs reduce handling while the GMDS/MYCN neuroblastoma study shows where conventional PCR can support, but not replace, spatial glycomics.

• FGFR3 Inhibition in SLC26A2 Chondrodysplasia

  2026-09-02

  The reference study combines genetic Fgfr3 ablation with pharmacological inhibition to show that excessive FGFR3 signaling contributes to SLC26A2-related chondrodysplasia in mice. NVP-BGJ398 improved chondrocyte differentiation, survival, and skeletal microarchitecture, supporting FGFR3 pathway inhibition as a translational research direction while leaving dose, selectivity, and human efficacy questions unresolved.

• IR-820: Turning NIR Signal Into Assay Insight

  2026-09-02

  IR-820, also known as New Indocyanine Green, is more than a near-infrared label: its value depends on how optical signal is connected to biological evidence. This guide explains assay design, formulation effects, and practical interpretation for vascular and tumor imaging.

• CCK8 Workflow for Renal Nanomedicine Studies

  2026-09-01

  Learn how to use the Cell Counting Kit-8 to distinguish carrier toxicity from treatment effects in renal nanomedicine experiments. This practical workflow combines calibration, nanoparticle-specific controls, and troubleshooting for more reliable cell proliferation, viability, and cytotoxicity data.

• D-Luciferin sodium salt for CAR-M Imaging

  2026-09-01

  D-Luciferin sodium salt enables sensitive firefly luciferase readouts for tracking engineered cells, tumor burden, and treatment response. This workflow-focused guide connects ATP-dependent imaging with the emerging mRNA-LNP CAR macrophage platform while emphasizing normalization, substrate handling, and assay-specific controls.

• From hly Biology to Faster, Trustworthy qPCR

  2026-08-31

  A translational perspective on how hly-linked biofilm biology in Listeria monocytogenes can shape more rigorous gene expression workflows, with practical guidance for fast, inhibitor-tolerant Green I qPCR.

• Pregnenolone Carbonitrile: A Translational PXR Probe

  2026-08-31

  Pregnenolone Carbonitrile, also known as Pregnenolone-16α-carbonitrile, is more than a conventional rodent PXR agonist. Its tissue-specific effects on cytochrome P450, hepatic detoxification, fibrosis biology, and hippocampal neurotoxicity make it a valuable mechanistic tool for translational researchers designing organ-aware validation strategies.

• Batimastat (BB-94) Workflows for MMP Research

  2026-08-30

  Batimastat (BB-94) combines broad nanomolar MMP inhibition with practical utility in biochemical, cell-based, tumor-invasion, and neuromuscular-junction assays. This guide shows how to turn its zinc-chelating mechanism into reproducible workflows while separating validated product data from cross-domain research hypotheses.

• CB-839 (Telaglenastat) Experimental Workflow

  2026-08-29

  Build stronger cancer metabolism studies with CB-839 (Telaglenastat), a selective GLS1 probe for linking glutamine use to proliferation, apoptosis, and autophagy. This guide combines practical assay design with insights from MYCN-amplified neuroblastoma research to improve metabolic interpretation and troubleshooting.

• GANT61: Mapping the GLI2–Ferroptosis Axis

  2026-08-28

  GANT61 is a GLI inhibitor for dissecting how GLI2-driven transcription influences ferroptosis and cisplatin response in bladder cancer. This article translates recent mechanistic evidence into a rigorous assay and interpretation framework.

7974 records 1/532 page Next 12345 下5页 Last page